New Article information at Pharmaceutical Technology New and updated information from Article listed on www.pharmaceutical-technology.com http://www.pharmaceutical-technology.com/ en-us http://www.pharmaceutical-technology.com/ New Article information at Pharmaceutical Technology http://www.pharmaceutical-technology.com/content/images/logo_big.gif Building Cure, Seattle Children’s Research Institute, Seattle http://www.pharmaceutical-technology.com/projects/building-cure-seattle-childrens-research-institute-seattle/ http://www.pharmaceutical-technology.com/projects/building-cure-seattle-childrens-research-institute-seattle/ Seattle Children's Research Institute (SCRI) is constructing a new paediatric research building named Building Cure at Stewart Street, Seattle, US. Fri, 24 Feb 2017 00:00:00 GMT Medicines Discovery Catapult: improving collaborative drug discovery in the UK http://www.pharmaceutical-technology.com/features/featuremedicines-discovery-catapult-improving-collaborative-drug-discovery-in-the-uk-5731276/ http://www.pharmaceutical-technology.com/features/featuremedicines-discovery-catapult-improving-collaborative-drug-discovery-in-the-uk-5731276/ The Medicines Discovery Catapult, one of 11 technology and innovation centres established by Innovate UK, has been set up to enable new, collaborative means of drug discovery. Abi Millar spoke to CEO Chris Molloy to find out more. Thu, 23 Feb 2017 00:00:00 GMT Therapeutic orphans: child-friendly drugs and the quest for adherence http://www.pharmaceutical-technology.com/features/featuretherapeutic-orphans-child-friendly-drugs-and-the-quest-for-adherence-5743204/ http://www.pharmaceutical-technology.com/features/featuretherapeutic-orphans-child-friendly-drugs-and-the-quest-for-adherence-5743204/ Most drugs are developed for adults, which poses real difficulties when the afflicted patients are children and often leads to very poor adherence. So, what needs to be done to make sure drugs are suitable and tolerable for children? A landmark initi… Tue, 21 Feb 2017 00:00:00 GMT Nigeria’s HIV ‘breakthrough’: separating truth from hope http://www.pharmaceutical-technology.com/features/featurenigerias-hiv-breakthrough-separating-truth-from-hope-5743177/ http://www.pharmaceutical-technology.com/features/featurenigerias-hiv-breakthrough-separating-truth-from-hope-5743177/ A Nigerian researcher’s claim to have developed a ‘cure’ for HIV has been enthusiastically received by local media, but the country’s top AIDS and disease control organisations have pointed out myriad flaws in the data. What can the ongoing debate ov… Mon, 20 Feb 2017 00:00:00 GMT A peptide to prevent pre-diabetes http://www.pharmaceutical-technology.com/features/featurea-peptide-to-prevent-pre-diabetes-5731416/ http://www.pharmaceutical-technology.com/features/featurea-peptide-to-prevent-pre-diabetes-5731416/ An Irish biotech start-up has joined the global battle against diabetes with an unexpected weapon of choice: food. Elly Earls meets the company’s founder and chief scientific officer Dr Nora Khaldi to find out more. Thu, 16 Feb 2017 00:00:00 GMT Pharma Technology Focus – Issue 56 http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-56-5740630/ http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-56-5740630/ In this issue: Clinical research in the UK, fighting diabetes with peptides, balancing speed and safety when reviewing new drugs, the potential of shark antibodies to treat Alzheimer’s, Elsevier’s new project to boost innovation, and more. Wed, 15 Feb 2017 15:57:00 GMT Why the UK NHS needs clinical research http://www.pharmaceutical-technology.com/features/featurewhy-the-uk-nhs-needs-clinical-research-5731315/ http://www.pharmaceutical-technology.com/features/featurewhy-the-uk-nhs-needs-clinical-research-5731315/ New data published by the UK’s National Institute for Health Research has revealed that for the first time ever, all NHS Trusts in England are engaged in clinical research. Abi Millar finds out why, at such a testing time for the NHS, a strong clinic… Mon, 13 Feb 2017 00:00:00 GMT BenevolentAI: using artificial intelligence to speed up drug discovery http://www.pharmaceutical-technology.com/features/featurebenevolentai-using-artificial-intelligence-to-speed-up-drug-discovery-5731295/ http://www.pharmaceutical-technology.com/features/featurebenevolentai-using-artificial-intelligence-to-speed-up-drug-discovery-5731295/ British artificial intelligence company BenevolentAI recently signed an exclusive license agreement for a series of novel clinical stage drug candidates with Johnson & Johnson. Their potential was evaluated using the company’s unique AI technology, w… Tue, 07 Feb 2017 00:00:00 GMT The Hive: new incubator makes a beeline for non-traditional pharma companies http://www.pharmaceutical-technology.com/features/featurethe-hive-new-incubator-makes-a-beeline-for-non-traditional-pharma-companies-5730514/ http://www.pharmaceutical-technology.com/features/featurethe-hive-new-incubator-makes-a-beeline-for-non-traditional-pharma-companies-5730514/ Elsevier’s new incubator project aims to highlight and bolster the incredible innovation taking place within pharmaceutical and biotech start-ups. Elly Earls catches up with Elsevier and two of the companies involved to find out more about The Hive a… Tue, 07 Feb 2017 00:00:00 GMT January's top stories: J&J to acquire Actelion for $30bn, Takeda to acquire ARIAD for $5.2bn http://www.pharmaceutical-technology.com/features/featurejanuarys-top-stories-jj-to-acquire-actelion-for-30bn-takeda-to-acquire-ariad-for-52bn-5730456/ http://www.pharmaceutical-technology.com/features/featurejanuarys-top-stories-jj-to-acquire-actelion-for-30bn-takeda-to-acquire-ariad-for-52bn-5730456/ J&J agreed to acquire Swiss biotech company Actelion for $30bn, and Japan’s Takeda agreed to acquire US cancer drug manufacturer ARIAD for $5.2bn. Pharmaceutical-technology.com wraps up the key headlines from January. Mon, 06 Feb 2017 00:00:00 GMT Leaf Systems Bioscience Research Facility, Norfolk http://www.pharmaceutical-technology.com/projects/leaf-systems-bioscience-research-facility-norfolk/ http://www.pharmaceutical-technology.com/projects/leaf-systems-bioscience-research-facility-norfolk/ Leaf Systems International opened its new bioscience research and development facility located at the Norwich Research Park in Norfolk, UK. Leaf Systems, a spin-off from John Innes Centre (JIC), will use the facility to produce proteins, metabolites … Fri, 03 Feb 2017 00:00:00 GMT Hovione API Facility Expansion, New Jersey http://www.pharmaceutical-technology.com/projects/hovione-api-facility-expansion-new-jersey/ http://www.pharmaceutical-technology.com/projects/hovione-api-facility-expansion-new-jersey/ Pharmaceutical company based in Portugal Hovione is carrying out an expansion of its active pharmaceutical ingredients (API) facility in East Windsor, New Jersey. Tue, 31 Jan 2017 00:00:00 GMT Tapping digital technologies to improve drug adherence http://www.pharmaceutical-technology.com/features/featuretapping-the-internet-to-improve-drug-adherence-5711300/ http://www.pharmaceutical-technology.com/features/featuretapping-the-internet-to-improve-drug-adherence-5711300/ Digital connected technologies are increasingly being used to improve patient adherence, one of the biggest challenges facing the healthcare system today. To find out more, Elly Earls talks to smart packaging developer Mevia and Internet of Things se… Mon, 23 Jan 2017 00:00:00 GMT Takeda and Ovid to Co-develop Drug for Rare Pediatric Epilepsies http://www.pharmaceutical-technology.com/features/featuretakeda-and-ovid-to-co-develop-drug-for-rare-pediatric-epilepsies-5721027/ http://www.pharmaceutical-technology.com/features/featuretakeda-and-ovid-to-co-develop-drug-for-rare-pediatric-epilepsies-5721027/ Fri, 20 Jan 2017 11:50:00 GMT Pharma Technology Focus – Issue 55 http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-55-5719431/ http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-55-5719431/ In this issue: India’s new drug pricing policy, bringing transparency to pharma industry payments, a UK innovation centre enabling new means of drug discovery, how artificial intelligence is being used in drug development, and more. Wed, 18 Jan 2017 15:21:00 GMT Pharma payments to doctors: seeking transparency http://www.pharmaceutical-technology.com/features/featurepharma-payments-to-doctors-seeking-transparency-5711295/ http://www.pharmaceutical-technology.com/features/featurepharma-payments-to-doctors-seeking-transparency-5711295/ A Europe-wide initiative bringing transparency to pharma industry payments to healthcare professionals and organisations has prompted a spirited debate across the continent. Ireland is no exception, with critics questioning the €27.2m paid to public … Mon, 16 Jan 2017 00:00:00 GMT After the cure: addressing side effects in childhood cancer patients http://www.pharmaceutical-technology.com/features/featureafter-the-cure-addressing-side-effects-in-childhood-cancer-patients-5711091/ http://www.pharmaceutical-technology.com/features/featureafter-the-cure-addressing-side-effects-in-childhood-cancer-patients-5711091/ While survival rates for childhood cancer have increased, many survivors are blighted by health problems later in life. According to a new study, these ‘late effects’ seem to be no better for more recently treated patients than for those who were tre… Thu, 12 Jan 2017 00:00:00 GMT How does the NHS weigh the costs of HIV preventing drugs? http://www.pharmaceutical-technology.com/features/featurehow-does-the-nhs-weigh-the-costs-of-hiv-preventing-drugs-5007956/ http://www.pharmaceutical-technology.com/features/featurehow-does-the-nhs-weigh-the-costs-of-hiv-preventing-drugs-5007956/ In August, the High Court ruled that NHS England can fund the use of PrEP – effective but very expensive drugs that prevent HIV infection. But with the NHS appealing that decision, it is unclear whether PrEP will ever be commissioned. Abi Millar expl… Thu, 12 Jan 2017 00:00:00 GMT India's drug price overhaul: a question of balance http://www.pharmaceutical-technology.com/features/featureindias-drug-price-overhaul-a-question-of-balance-5711341/ http://www.pharmaceutical-technology.com/features/featureindias-drug-price-overhaul-a-question-of-balance-5711341/ India’s drug pricing policy is set for an overhaul, but has the government struck the right balance between ensuring affordable access to medicines and creating a regulatory landscape that works for the industry? Elly Earls investigates. Mon, 09 Jan 2017 00:00:00 GMT Agilent Technologies’ New Pharmaceutical Facility, Frederick, Colorado http://www.pharmaceutical-technology.com/projects/agilent-technologies-new-pharmaceutical-facility-frederick-colorado/ http://www.pharmaceutical-technology.com/projects/agilent-technologies-new-pharmaceutical-facility-frederick-colorado/ Agilent Technologies initiated the construction of a new multi-structure pharmaceutical manufacturing plant at Frederick in Weld County, Colorado, US, in October 2016. Wed, 04 Jan 2017 00:00:00 GMT